Research ArticleExperimental Studies
Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4
ATSUSHI YAMAGUCHI, YUTO MUKAI, TOMOYA SAKUMA, AYAKO FURUGEN, KATSUYA NARUMI and MASAKI KOBAYASHI
Anticancer Research July 2023, 43 (7) 3015-3022; DOI: https://doi.org/10.21873/anticanres.16472
ATSUSHI YAMAGUCHI
1Department of Pharmacy, Hokkaido University Hospital, Sapporo, Japan;
2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
YUTO MUKAI
2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
TOMOYA SAKUMA
2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
AYAKO FURUGEN
2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
KATSUYA NARUMI
2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
MASAKI KOBAYASHI
2Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Atorvastatin Exerts More Selective Inhibitory Effects on hMCT2 than on hMCT1 and hMCT4
ATSUSHI YAMAGUCHI, YUTO MUKAI, TOMOYA SAKUMA, AYAKO FURUGEN, KATSUYA NARUMI, MASAKI KOBAYASHI
Anticancer Research Jul 2023, 43 (7) 3015-3022; DOI: 10.21873/anticanres.16472
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.